Literature DB >> 21385524

Recent advances in understanding the role of diet and obesity in the development of colorectal cancer.

Elizabeth K Lund1, Nigel J Belshaw, Giles O Elliott, Ian T Johnson.   

Abstract

Colorectal cancer (CRC) is a major cause of premature death in the UK and many developed countries. However, the risk of developing CRC is well recognised to be associated not only with diet but also with obesity and lack of exercise. While epidemiological evidence shows an association with factors such as high red meat intake and low intake of vegetables, fibre and fish, the mechanisms underlying these effects are only now being elucidated. CRC develops over many years and is typically characterised by an accumulation of mutations, which may arise as a consequence of inherited polymorphisms in key genes, but more commonly as a result of spontaneously arising mutations affecting genes controlling cell proliferation, differentiation, apoptosis and DNA repair. Epigenetic changes are observed throughout the progress from normal morphology through formation of adenoma, and the subsequent development of carcinoma. The reasons why this accumulation of loss of homoeostatic controls arises are unclear but chronic inflammation has been proposed to play a central role. Obesity is associated with increased plasma levels of chemokines and adipokines characteristic of chronic systemic inflammation, and dietary factors such as fish oils and phytochemicals have been shown to have anti-inflammatory properties as well as modulating established risk factors such as apoptosis and cell proliferation. There is also some evidence that diet can modify epigenetic changes. This paper briefly reviews the current state of knowledge in relation to CRC development and considers evidence for potential mechanisms by which diet may modify risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385524     DOI: 10.1017/S0029665111000073

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  12 in total

Review 1.  XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.

Authors:  Chang-Jiang Qin; Kai-Wu Xu; Zhi-Hui Chen; Er-Tao Zhai; Yu-Long He; Xin-Ming Song
Journal:  Tumour Biol       Date:  2015-01-13

2.  Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk.

Authors:  Amy Y Liu; Dominique Scherer; Elizabeth Poole; John D Potter; Karen Curtin; Karen Makar; Martha L Slattery; Bette J Caan; Cornelia M Ulrich
Journal:  Mol Nutr Food Res       Date:  2012-09-07       Impact factor: 5.914

Review 3.  The critical roles of miR-21 in anti-cancer effects of curcumin.

Authors:  Jiezhong Chen; Tiefeng Xu; Chen Chen
Journal:  Ann Transl Med       Date:  2015-12

4.  Dietary patterns during high school and risk of colorectal adenoma in a cohort of middle-aged women.

Authors:  Katharina Nimptsch; Vasanti S Malik; Teresa T Fung; Tobias Pischon; Frank B Hu; Walter C Willett; Charles S Fuchs; Shuji Ogino; Andrew T Chan; Edward Giovannucci; Kana Wu
Journal:  Int J Cancer       Date:  2013-11-25       Impact factor: 7.396

5.  Obesity, metabolic factors, and colorectal adenomas: a retrospective study in a racially diverse New York State Hospital.

Authors:  Seth Lipka; Xi Emily Zheng; Jorge Hurtado-Cordovi; Jaspreet Singh; Evan Levine; Raymond Vlacancich; Bhuma Krishnamachari; Min-Kyung Jung; Shuang Fu; Umeko Takeshige; Boris Avezbakiyev; Ting Li; Javed Iqbal; Kaleem Rizvon; Paul Mustacchia
Journal:  J Gastrointest Cancer       Date:  2013-09

6.  Association of total energy intake and macronutrient consumption with colorectal cancer risk: results from a large population-based case-control study in Newfoundland and Labrador and Ontario, Canada.

Authors:  Zhuoyu Sun; Lin Liu; Peizhong Peter Wang; Barbara Roebothan; Jin Zhao; Elizabeth Dicks; Michelle Cotterchio; Sharon Buehler; Peter T Campbell; John R McLaughlin; Patrick S Parfrey
Journal:  Nutr J       Date:  2012-03-26       Impact factor: 3.271

Review 7.  Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes.

Authors:  Craig S Nunemaker
Journal:  J Diabetes Res       Date:  2016-10-23       Impact factor: 4.011

8.  PPARG rs3856806 C>T Polymorphism Increased the Risk of Colorectal Cancer: A Case-Control Study in Eastern Chinese Han Population.

Authors:  Jing Lin; Yu Chen; Wei-Feng Tang; Chao Liu; Sheng Zhang; Zeng-Qing Guo; Gang Chen; Xiong-Wei Zheng
Journal:  Front Oncol       Date:  2019-02-19       Impact factor: 6.244

9.  Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism.

Authors:  Janani Panneerselvam; Venkateshwar Madka; Rajani Rai; Katherine T Morris; Courtney W Houchen; Parthasarathy Chandrakesan; Chinthalapally V Rao
Journal:  Cancers (Basel)       Date:  2021-10-14       Impact factor: 6.639

Review 10.  Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.

Authors:  Faraz Bishehsari; Mahboobeh Mahdavinia; Michele Vacca; Reza Malekzadeh; Renato Mariani-Costantini
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.